News >

FDA Approves Trastuzumab Biosimilar

Jason M. Broderick @jasoncology
Published: Friday, Dec 01, 2017

The FDA has approved the trastuzumab (Herceptin) biosimilar MYL-1401O (Ogivri; trastuzumab-dkst), which is co-developed by Mylan and Biocon.

).

Table 

Table


... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x